Resultatet af den videnskabelige analyse var ledsaget af en koordineret kommunikationsstrategi mellem EMEA og de nationale kompetente myndigheder.
The EMEA continued its interaction with the US Food and Drug Administration, not only through the work of the ICH process, but also as part of the US-EU Trans-Atlantic Business